This inventor holds 4 USPTO granted patents. Top assignees: Neos Therapeutics, LP, Uniwell Laboratories, LLC. Active years: 2013-2021.
Location History:
- Forth Worth, TX (US) (2013 - 2015)
- Fort Worth, TX (US) (2013 - 2021)
Company Filing History:
Years Active: 2013-2021
Title: The Innovative Contributions of Michael Sloane
Introduction
Michael Sloane is a notable inventor based in Fort Worth, TX (US), recognized for his significant contributions to the pharmaceutical industry. With a total of 4 patents, Sloane has developed innovative methods and compositions that enhance the accuracy and effectiveness of pharmaceutical dosing.
Latest Patents
Sloane's latest patents include groundbreaking advancements in pharmaceutical compositions. One of his notable inventions involves individually metering and dispensing specific volumes and/or weights of each component of a dosage. This method ensures that the components for each dose are secured with very high accuracy. The invention also describes a method for dosing a pharmaceutical product in a sealed container, such as a packet, sachet, or blister pack. This dosage may include a thickening agent as a carrier, allowing the active ingredient to dissolve in the mouth without the need for water.
Another significant patent focuses on methods of formulating and designing liquid drug suspensions containing ion exchange resin particles. This invention relates to the formulation and quality control of liquid drug suspensions, particularly those comprising drug-containing resin particles. Sloane's work includes methods for confirming the acceptability of these particles and achieving desired in vitro dissolution profiles.
Career Highlights
Throughout his career, Michael Sloane has worked with reputable companies such as Neos Therapeutics, LP and Uniwell Laboratories, LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and product development.
Collaborations
Sloane has collaborated with talented individuals in the field, including Russell McMahen and Mark Tengler. These partnerships have further enriched his work and contributed to the advancement of pharmaceutical technologies.
Conclusion
Michael Sloane's innovative contributions to the pharmaceutical industry demonstrate his commitment to improving drug formulation and delivery methods. His patents reflect a deep understanding of the complexities involved in pharmaceutical development, making him a valuable figure in the field.